AI assistant
Sending…
STEPAN CO — Director's Dealing 2023
Mar 1, 2023
32175_dirs_2023-03-01_5990fa70-db62-4979-b16b-9f7263662fab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEPAN CO (SCL)
CIK: 0000094049
Period of Report: 2023-02-27
Reporting Person: STEPAN F QUINN JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-27 | Common Stock | M | 12067 | $61.91 | Acquired | 240231.507 | Direct |
| 2023-02-27 | Common Stock | S | 12067 | $105.2773 | Disposed | 228164.507 | Direct |
| 2023-02-28 | Common Stock | M | 155 | $61.91 | Acquired | 228319.507 | Direct |
| 2023-02-28 | Common Stock | S | 75 | $105.05 | Disposed | 228244.507 | Direct |
| 2023-02-28 | Common Stock | S | 80 | $105.06 | Disposed | 228164.507 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-27 | Employee Stock Option (Right to Buy) | $61.91 | M | 12067 | Disposed | 2024-02-17 | Common Stock (12067) | Direct |
| 2023-02-28 | Employee Stock Option (Right to Buy) | $61.91 | M | 155 | Disposed | 2024-02-17 | Common Stock (155) | Direct |
Footnotes
F1: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $105.00 to $105.98, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer.
More from STEPAN CO
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Feb 23